Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein arginine methyltransferase 1 pseudogene 1 (PRMT1P1) is a genomic sequence classified as a pseudogene, meaning it closely resembles the coding gene for protein arginine methyltransferase 1 (PRMT1) but does not produce a functional protein[1][3]. Pseudogenes like PRMT1P1 typically arise from gene duplication or retrotransposition and subsequently accumulate disabling mutations, such as premature stop codons or frameshifts, that result in loss of function[3]. PRMT1P1 may be transcribed at low levels, but its RNA product does not have established functional significance. PRMT1P1 is not a receptor, enzyme, or any other therapeutic target, and current evidence does not ascribe it a clinical role in disease or therapy[3]. If you intended to search for the functional protein arginine methyltransferase 1 (PRMT1), then that is a distinct, functional enzyme with established biological, therapeutic, and disease relevance[2][4]. The name "PRMT1P1" refers specifically to the pseudogene and not to the active enzyme.
None — mechanism of action information is not applicable to pseudogenes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein arginine methyltransferase 1 pseudogene 1 (PRMT1P1).